Epidemiological study of mucormycosis cases admitted at civil hospital, ahmedabad during covid-19 pandemic

Background: An Epidemic of Mucormycosis along with second wave of covid-19 pandemic was seen in Gujarat and other states also which was very serious problem. So, aim of this study was to know the epidemiology of mucormycosis during covid-19 pandemic.
Methods: A Cross-sectional study was conducted at Civil Hospital, Ahmedabad which included total of 769 confirmed cases of mucormycosis admitted between 11th May to 21st June, 2021. Information like socio-demography, diagnosis, clinical features, Site of infection, Risk factors etc. were collected.
Results: It was observed that 2/3rd of Males and 1/3rd of Females were affected. The mean age was 53.2 12.6years. 78.9 % of patients had history of Covid 19 disease in the past and among them 70.0% were treated with steroids, 45.3% required Oxygen therapy during Covid. Of total, 17.0 % were Partially vaccinated, 4.2% were fully vaccinated. Headache (58.5%) was observed as most common clinical manifestation of Mucormycosis and Para-nasal sinus (57.6%) was most commonly affected site. Diabetes (71.9 %) was found to be the most common comorbidity. There was no significant association found between diabetes and covid-19 status of patients. (p= 0.2794)
Conclusion: Cases of mucor were prominently seen in the patients who had h/o covid-19 infection with concurrent use of steroid and who were diabetic. So judicial use of steroid, regular monitoring of blood sugar level must be ensured among covid-19 disease management.